Cafepharma Today

May 15 2024 - Novo Nordisk owner buys majority stake in Austrian life science tools company
Novo Nordisk owner buys majority stake in Austrian life science tools company
Winners and losers in biopharma’s Q1 2024 earnings season
As sales of weight loss drugs skyrocket, the insulin market falters
Eisai starts rolling submission for injectable version of Alzheimer's drug with FDA
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Pharmaceutical to enter Japan via joint venture
Marketwatch
Tuesday, September 23, 2008 - 7:29am
tags:
Key PDL patents under fire
Bizjournals.com
Tuesday, September 23, 2008 - 7:28am
tags:
BMY Ups the Ante on ImClone
Seeking Alpha
Tuesday, September 23, 2008 - 7:24am
tags:
Credit Suisse upgrades Novartis, downgrades Sanofi-Aventis
Marketwatch
Tuesday, September 23, 2008 - 7:24am
tags:
Bristol-Myers Squibb, ImClone Systems report positive long-term Erbitux study data
Yahoo/AP
Monday, September 22, 2008 - 5:09pm
tags:
Pfizer retooling, pushing emerging market sales
Yahoo/AP
Monday, September 22, 2008 - 5:08pm
tags:
Ouch, That's Gotta Hurt! (Effexor vs. Acupuncture)
Motley Fool
Monday, September 22, 2008 - 4:33pm
tags:
CytRx closes on Innovive
Bizjournals.com
Monday, September 22, 2008 - 4:29pm
tags:
FDA Fall Decision Calendar Features Some Likely Near-Term Movers
Seeking Alpha
Monday, September 22, 2008 - 4:28pm
tags:
Why Bristol-Myers Won't Pull Its ImClone Bid
Motley Fool
Monday, September 22, 2008 - 4:27pm
tags:
Let's Bail Out Pharma Next
Motley Fool
Monday, September 22, 2008 - 4:26pm
tags:
inVentiv inTrouble?
Motley Fool
Monday, September 22, 2008 - 4:26pm
tags:
Merck Growth Outlook Flattening
Yahoo/Zacks.com
Monday, September 22, 2008 - 4:23pm
tags:
Dynavax gets $4.5 million payment
Bizjournals.com
Monday, September 22, 2008 - 4:22pm
tags:
Moody's: Pharmaceutical industry outlook is negative, especially for branded drugmakers
Yahoo/AP
Monday, September 22, 2008 - 4:21pm
tags:
Drug shares slide into red, but AstraZeneca climbs
Marketwatch
Monday, September 22, 2008 - 4:20pm
tags:
A Closer Look at La Jolla’s Riquent
Cafepharma Detailpiece
Monday, September 22, 2008 - 10:48am
tags:
Cash-poor patients cut back on meds
Fierce Pharma
Monday, September 22, 2008 - 10:47am
tags:
Novartis eyes MediGene's cancer drug - sources
Hemscott, UK
Monday, September 22, 2008 - 10:45am
tags:
Decision due soon on Lilly, Daiichi blood thinner
Guardian, UK
Monday, September 22, 2008 - 10:45am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Manager II, Queens - NY
New York City, New York
Thermo Fisher Scientific Careers
Global Launch Education Product Manager - Austin, TX
Austin, TX, 78716
Abbott Laboratories
BioPharmaceutical Account Manager - Saint Louis West, MO
Saint Louis, MO, 63190
Lundbeck
Cardiovascular Medical Science Liaison (Contract)
San Francisco, CA, 94102
BESTMSLs
Hospice Care Consultant
Sandwich, MA, 02563
Gentiva Hospice
Hospice Care Consultant
Lenexa, KS, 66215
Gentiva Hospice
Hospice Care Consultant
Kansas City, MO, 64124
Gentiva Hospice
Hospice Care Consultant
Kansas City, MO, 64149
Gentiva Hospice
Hospice Care Consultant
Lansing, KS, 66043
Gentiva Hospice
Hospice Care Consultant
Smithville, MO, 64089
Gentiva Hospice
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information